InvestorsHub Logo
icon url

misiu143

08/14/21 2:04 PM

#178993 RE: Badge04 #178989

Well , I hope this will give us an approval , but not follow up with treatment with leronlimab on outpatient up to 4 doses if needed , is taking unnecessary risk with patients life and our study..
3 and 4 dose should be given every 1 week if needed for patients discharge for egc after 2 weeks treatment imo

I know you are also a physician but I just have a different opinion here..

GLTU.